Eris Lifesciences informs about outcome of board meeting

04 Aug 2020 Evaluate

Eris Lifesciences has informed that the Board of Directors of the Company at their meeting held today August 04, 2020, duly approved / took on record the Unaudited Standalone Financial Results and the Unaudited Consolidated Financial Results for the quarter ended June 30, 2020, Declaration of Interim Dividend of Rs 5.50 (at the rate of 550%) on each fully paid-up equity share of Re 1 for the Financial Year 2020-21, and Fixed 14th August, 2020 as the record date to determine the names of the equity shareholders, who shall be entitled to receive the payment towards interim dividend for the financial year 2020-21. The payment of the interim dividend would be made to the eligible shareholders on or before 3rd September, 2020. The meeting of the Board of Directors commenced at 11:00 am and concluded at 01:05 pm.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1407.90 18.20 (1.31%)
19-Dec-2024 11:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1801.25
Dr. Reddys Lab 1322.30
Cipla 1489.70
Lupin 2116.45
Zydus Lifesciences 984.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.